Comparing Bavencio vs Keytruda
Bavencio (avelumab) | Keytruda (pembrolizumab) |
|
---|
Bavencio (avelumab) | Keytruda (pembrolizumab) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Merkel Cell Carcinoma, Urothelial Carcinoma, Renal Cell Carcinoma. Bavencio may also be used for purposes not listed in this medication guide. |
Prescription only
Keytruda is an immunotherapy treatment called a checkpoint inhibitor that helps your immune system fight cancer and is used to treat many different types of cancer in adults and children including... View more |
Related suggestions Urothelial Carcinoma
Merkel Cell Carcinoma
Popular comparisons
|
|||||||||||||||
More about Bavencio (avelumab) | More about Keytruda (pembrolizumab) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Be the first to share your experience with this drug. |
Keytruda has an average rating of 5.0 out of 10 from a total of 259 ratings on Drugs.com. 41% of reviewers reported a positive effect, while 47% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Bavencio side effects |
View all Keytruda side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Bavencio prices |
View all Keytruda prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
146.4 hours |
624 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 597 drugs are known to interact with Bavencio:
|
A total of 596 drugs are known to interact with Keytruda:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
March 23, 2017 |
N/A |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.